Retrospective Study of Genetic Diversity of Acinetobacter Baumannii-Resistant Strains Isolated from Patients in Rīga East University Hospital in Latvia
References
- Adams, M. D., Chan, E. R., Molyneaux, N. D., Bonomo, R. A. (2010). Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.,54 (9), 3569–3577.10.1128/AAC.00057-10293497120530228
- Anonymous (2016a). Carbapenem-resistant Acinetobacter baumannii in healthcare settings. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-carbapenem-resistant-acinetobacter-baumannii-healthcare (accessed 12.04.2021).
- Anonymous (2016b). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version 5.3. European Centre for Disease Prevention and Control, Stockholm. https://www.ecdc.europa.eu/en/publications-data/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use-3 (accessed 12.04.2021).
- Anonymous (2016c). Surveillance Atlas of Infectious Diseases — Antimicrobial resistance. https://ecdc.europa.eu/en/antimicrobial-resistance/surveil-lance-and-disease-data/data-ecdc (accessed 12.04.2021).
- Anonymous (2017). WHO publishes list of bacteria for which new antibiotics are urgently needed.http://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed 12 April 2021).
- Bouvet, P. J., Grimont, P. A. (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov. Acinetobacter haemolyticus sp. nov. Acinetobacter johnsonii sp. nov. and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwofii. Int. J. Syst. Bacteriol.,36 (2), 228–240.10.1099/00207713-36-2-228
- Brossard, K. A., Campagnari, A. A. (2012). The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun.,80 (1), 228–233.10.1128/IAI.05913-11325568422083703
- Chen, L., Zheng, D., Liu, B., Yang, J., Jin, Q. (2016). VFDB 2016: Hierarchical and refined dataset for big data analysis —10 years on. Nucl. Acids Res.,44, D694–D697.10.1093/nar/gkv1239470287726578559
- Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., Brisse, S. (2010). The population structure of Acinetobacter baumannii: Expanding multi-resistant clones from an ancestral susceptible genetic pool. PLoS One., 5 (4), e10034.10.1371/journal.pone.0010034285092120383326
- Perez, F. Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.,51 (10) 3471–3484.10.1128/AAC.01464-06204329217646423
- Fishbain, J., Peleg, A. Y. (2010). Treatment of Acinetobacter infections. Clin. Infect. Dis.,51 (1), 79–84.10.1086/65312020504234
- Fitzpatrick, M. A., Ozer, E. A, Hauser, A. R. (2016). Utility of whole genome sequencing in characterizing Acinetobacter epidemiology and analyzing hospital outbreaks. J. Clin. Microbiol.,54, 593–612.10.1128/JCM.01818-15476797226699703
- Fournier, P. E., Richet, H. (2006). The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis.,42 (5), 692–699.10.1086/50020216447117
- Gramatniece, A., Silamikelis, I., Zahare, I., Urtans, V., Zahare, I., Dimina, E., Saule, M., Balode, M., Radovica-Spalvina, I., Klovins, J., Fridmanis, D., Dumpis, U. (2019). Control of Acinetobacter baumannii outbreak in the neonatal intensive care unit in Latvia: Whole-genome sequencing powered investigation and closure of the ward. Antimicrob. Resist. Infect. Control,8, 84.10.1186/s13756-019-0537-z653225631143444
- Higgins, P. G., Prior, K., Harmsen, D., Seifert, H. (2017). Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii. PLoS ONE., 12, e0179228.10.1371/journal.pone.0179228546462628594944
- Jünemann, S., Sedlazeck, F. J., Prior, K., Albersmeier, A., John, U., Kalinowski, J., Mellmann, A., Goesmann, A., Haeseler, A. von, Stoye, J., Harmsen, D. (2013). Updating benchtop sequencing performance comparison. Nat. Biotechnol.,31 (4), 294–296.10.1038/nbt.252223563421
- Kanafani, Z. A., Souha, S. K. (2021). Acinetobacter infection: Epidemiology, microbiology, pathogenesis, clinical features, and diagnosis. https://www.uptodate.com/contents/acinetobacter-infection-epidemiology-microbiology-pathogenesis-clinical-features-and-diagnosis (accessed 12.04.2021).
- Kim, S. J., Kim, Y.-J., Ko, K. S., (2018). Genomic analysis of consecutive Acinetobacterbumanii strains from a single patient. Front Microbiol., 9, 2840.10.3389/fmicb.2018.02840627777530542330
- Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae I. K., Kim, Y. B, Cha, C. J. C., Jeong, B. C., Lee, S. H. (2017). Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol.,7, 55.10.3389/fcimb.2017.00055534658828348979
- Liepiņš, M., Sīmanis, R., Lejnieks, A. (2016). Decreasing prevalence of multidrug-resistant Acinetobacter Baumannii in Rīga East University Hospital. Proc. Latvian Acad. Sci.,70 (4), 232–236.10.1515/prolas-2016-0037
- Maragakis, L. L., Perl, T. M. (2008). Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis.,46 (8), 1254–1263.10.1086/52919818444865
- Mazumder, S. A. (2021). Acinetobacter.https://emedicine.medscape.com/article/236891-overview (accessed 8 March 2021).
- O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance.https://www.biomerieuxconnection.com/wp-content/uploads/2018/04/Tackling-Drug-Resistant-Infections-Globally_-Final-Report-and-Recommendations.pdf (accessed 12.04.2021).
- Owens, R. C., Jr., Rice, L. (2006). Hospital-based strategies for combating resistance. Clin. Infect. Dis., 42 (Suppl. 4), S173–S181.10.1086/50066416544268
- Park, S. Y., Choo, J. Y., Kwon, S. H, Yu, S. N., Lee, E. J., Kim, T. H., Choo, E. J., Jeon, M. H. (2013). Risk factors for mortality in patients with Acinetobacter baumannii bacteremia. Inf. Chemother.,45 (3), 325–330.10.3947/ic.2013.45.3.325384851124396634
- Rice, L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis.,197 (8), 1079–1081.10.1086/53345218419525
- Sefid, F., Rasooli, I., Jahangiri, A., Bazmara, H. (2015). Functional exposed amino acids of BauA as potential immunogen against Acinetobacter baumannii. Acta Biotheor.,63 (2),129–149.10.1007/s10441-015-9251-225840681
- Xiao, D., Wang, L., Zhang, D., Xiang, D., Liu, Q., Xing, X. (2017). Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis. Exper. Ther. Med.,13 (4), 1630–1633.10.3892/etm.2017.4137537756928413520
- Zerbino, D.R., Birney, E. (2008). Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res., 18 (5), 821–829.10.1101/gr.074492.107233680118349386
Language: English
Page range: 142 - 148
Submitted on: Jul 22, 2020
Accepted on: Apr 13, 2021
Published on: May 8, 2021
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Related subjects:
© 2021 Māris Liepiņš, Angelika Krūmiņa, Irēna Meistere, Diāna Kosjkina, Juris Ķibilds, Olga Valciņa, Aivars Lejnieks, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.